Fujifilm, GE Near Escape From Tumor Monitoring Patent Suit
U.S. District Judge Gonzalo P. Curiel held that biotechnology company AntiCancer hasn’t produced any evidence to support its contention of direct infringement in response to GE’s and Fujifilm’s requests for further information. He granted the defendants’ motion for summary judgment of noninfringement.
AntiCancer also alleges that a former Fujifilm sales associate...
To view the full article, register now.